Stem cell biologist with solid experience in immunology, having run an analytics core for stem cell derived cell therapies, studied the effects of splicing factor mutations as founding mutations for blood cancers, become an expert in hematopoiesis, explored the immune mechanisms of bats, and established multiple CRISPR screens. Excels in a startup environment, bridges the gap between bench scientists and bioinformaticians, enjoys problem solving, and is well versed with balancing exploration with meeting deadlines and FDA requirements.Top achievements include: establishing metabolomics profiling of the first naive human embryonic stem cell line in North America, patenting and licensing of the utilization of let-7 over expression to accelerate cardiomyocyte maturation, and establishing culture and characterization methods as the third person in the world to work with bat iPSCs.